Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 58 Squamous Cell Carcinoma of Head and Neck 37 Nasopharyngeal Carcinoma 27 Lung Neoplasms 25 Uterine Cervical Neoplasms 22 Biliary Tract Neoplasms 22 Esophageal Squamous Cell Carcinoma 20 Oropharyngeal Neoplasms 18 Head and Neck Neoplasms 17 Cholangiocarcinoma 16 Urinary Bladder Neoplasms 14 Neoplasms 14 Neoplasm Metastasis 14 Ovarian Neoplasms 13 Esophageal Neoplasms 12 Carcinoma 12 Colorectal Neoplasms 11 Stomach Neoplasms 10 Small Cell Lung Carcinoma 10 Carcinoma, Transitional Cell 8 Mouth Neoplasms 7 Laryngeal Neoplasms 7 Hypopharyngeal Neoplasms 7 Carcinoma, Squamous Cell 7 Recurrence 6 Nasopharyngeal Neoplasms 5 Endometrial Neoplasms 5 Breast Neoplasms 5 Bile Duct Neoplasms 5 Peritoneal Neoplasms 4

Interventions

tislelizumab 1 pamiparib 1 Injections 1 Docetaxel 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Locally Advanced Prostate Cancer × Cisplatin × Clear all

NCT06387056 2024-04-26

SEGNO

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Locally Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡